A randomized controlled trial evaluated the effects of a lifestyle intervention on nonalcoholic steatohepatitis (NASH). Thirty-one overweight or obese individuals with biopsy-proven NASH were randomized to either an intensive lifestyle intervention (LS) group or a control group. The LS group received a 7-10% weight loss program involving diet, exercise, and behavior modification, while the control group received structured education. After 48 weeks, the LS group lost an average of 9.3% of their weight, compared to 0.2% in the control group. The LS group showed significant improvements in NASH histologic activity score (NAS), with a reduction from 4.4 to 2.0, compared to the control group's reduction from 4.9 to 3.5. Participants who achieved at least 7% weight loss had greater improvements in steatosis, lobular inflammation, and NAS. The study concluded that weight reduction through lifestyle intervention leads to improvements in liver histology in NASH. The primary outcome was a reduction in NAS by at least 3 points or a post-treatment NAS of 2 points or less. The study found that weight loss correlated with improvements in liver chemistry and histologic activity. Adverse events were minimal, and no significant differences in fibrosis were observed. The study highlights the effectiveness of lifestyle intervention in managing NASH, with significant improvements in liver histology and biochemical markers. The results suggest that a 7-10% weight loss can lead to significant improvements in NASH.A randomized controlled trial evaluated the effects of a lifestyle intervention on nonalcoholic steatohepatitis (NASH). Thirty-one overweight or obese individuals with biopsy-proven NASH were randomized to either an intensive lifestyle intervention (LS) group or a control group. The LS group received a 7-10% weight loss program involving diet, exercise, and behavior modification, while the control group received structured education. After 48 weeks, the LS group lost an average of 9.3% of their weight, compared to 0.2% in the control group. The LS group showed significant improvements in NASH histologic activity score (NAS), with a reduction from 4.4 to 2.0, compared to the control group's reduction from 4.9 to 3.5. Participants who achieved at least 7% weight loss had greater improvements in steatosis, lobular inflammation, and NAS. The study concluded that weight reduction through lifestyle intervention leads to improvements in liver histology in NASH. The primary outcome was a reduction in NAS by at least 3 points or a post-treatment NAS of 2 points or less. The study found that weight loss correlated with improvements in liver chemistry and histologic activity. Adverse events were minimal, and no significant differences in fibrosis were observed. The study highlights the effectiveness of lifestyle intervention in managing NASH, with significant improvements in liver histology and biochemical markers. The results suggest that a 7-10% weight loss can lead to significant improvements in NASH.